New indications for antiIL-1-beta therapy

Details for Australian Patent Application No. 2008257520 (hide)

Owner Novartis AG

Inventors Gram, Hermann; Jung, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2008257520

PCT Pub. Number WO2008/145664

Priority 07109084.9 29.05.07 EP

Filing date 28 May 2008

Wipo publication date 4 December 2008

Acceptance publication date 5 April 2012

International Classifications

C07K 14/545 (2006.01) Peptides having more than 20 amino acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2008/145664 Priority application(s): WO2008/145664

5 April 2012 Application Accepted

  Published as AU-B-2008257520

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008257525-Device for balance and body orientation support

2008257519-Ventilator apparatus and system for ventilation